Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. ASYS shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Amtech reported quarterly sales of $27.70 million, missing the analyst consensus estimate of $34.50 million. The company anticipated first-quarter revenue to be between $21 million and $24 million, versus the $34.15 million estimate.

Benchmark analyst Mark Miller downgraded Amtech Systems from Buy to Hold.

Amtech Systems shares fell 30.6% to $4.16 on Thursday.

Here are some other stocks moving in today's mid-day session.


  • Freight Technologies, Inc. FRGT shares jumped 322% to $1.14 after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.
  • SRIVARU Holding Limited SVMH rose 74.8% to $0.7000.
  • XBP Europe Holdings, Inc. XBP shares gained 49% to $8.46 after declining around 20% on Wednesday.
  • TPI Composites, Inc. TPIC rose 46% to $3.1350 as the company announced refinancing transaction with Oaktree, significantly strengthening company’s liquidity position and enhancing financial flexibility.
  • Nxu, Inc. NXU rose 43.6% to $0.0280 after the company signed a letter of intent outlining investment in Lynx Motors.
  • Canterbury Park Holding Corporation CPHC rose 31% to $18.70.
  • View, Inc. VIEW gained 29% to $5.14.
  • Hanryu Holdings, Inc. HRYU gained 27.1% to $1.3850 after jumping 28% on Wednesday.
  • Esperion Therapeutics, Inc. ESPR shares climbed 23.2% to $1.8603. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.
  • Redfin Corporation RDFN gained 21.8% to $10.26.
  • Codexis, Inc. CDXS shares surged 20.5% to $2.5184. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.
  • Vista Gold Corp. VGZ gained 20% to $0.4010. Vista Gold announced a $20 million royalty with Wheaton Precious Metals Corp. on Mt Todd.
  • Altice USA, Inc. ATUS rose 18.8% to $2.4950.
  • Sunnova Energy International Inc. NOVA gained 18.3% to $14.09.
  • Wayfair Inc. W rose 17.3% to $66.75.
  • Sunrun Inc. RUN gained 16.7% to $17.42.
  • Blend Labs, Inc. BLND surged 16.7% to $2.1950. Blend Labs Head of Finance and Admin. Amir Jafari acquired a total of 12,610 shares at an average price of $1.22.
  • Moderna, Inc. MRNA rose 15.8% to $91.14. Moderna and Merck & Co announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with Keytruda in patients with resected high-risk melanoma (stage III/IV) following complete resection.
  • VCI Global Limited VCIG gained 15.4% to $2.62 after its financial technology arm, Accuventures Sdn Bhd, agreed to acquire the Malaysian digital platform EVOLET.
  • Pacific Biosciences of California, Inc. PACB surged 14.2% to $10.12. Stephens & Co. initiated coverage on Pacific Biosciences with an Overweight rating and announced a price target of $11.
  • Alector, Inc. ALEC rose 14.8% to $7.92. Stifel upgraded Alector from Hold to Buy and raised the price target from $8 to $15.
  • Opendoor Technologies Inc. OPEN gained 14.4% to $4.71.
  • Enphase Energy, Inc. ENPH rose 13.6% to $122.22.
  • Plug Power Inc. PLUG gained 12.7% to $4.8550.
  • Alcoa Corporation AA gained 11% to $28.84. Alcoa received approval for continued mining in Western Australia.
  • RH RH gained 7.3% to $304.60.


  • Reneo Pharmaceuticals, Inc. RPHM shares dipped 87.3% to $0.9861. Reneo Pharmaceuticals said its pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoint.
  • Mynd.ai, Inc. MYND fell 53.1% to $2.71.
  • Cepton, Inc. CPTN fell 24.2% to $3.01 after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast. Craig-Hallum downgraded Cepton from Buy to Hold.
  • Apellis Pharmaceuticals, Inc. APLS declined 20.7% to $49.81 after the company announced it was informed of a negative trend vote on the marketing authorization application for pegcetacoplan.
  • NextCure, Inc. NXTC fell 20.7% to $1.15 after the company issued year-end clinical pipeline updates.
  • MIND Technology, Inc. MIND dipped 19.4% to $4.7414 following weak quarterly results.
  • Aditxt, Inc. ADTX fell 16.4% to $5.26.
  • Ocular Therapeutix, Inc. OCUL shares fell 15.1% to $3.3450. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.
  • NextPlay Technologies, Inc. NXTP shares fell 11.4% to $1.3905 after jumping 68% on Wednesday.
  • Regis Corporation RGS shares fell 9.9% to $8.39. NYSE will begin delisting proceedings against Regis Corp.
  • ABM Industries Incorporated ABM dipped 9.5% to $47.33. ABM recently reported better-than-expected fourth-quarter financial results and issued guidance.
  • Intensity Therapeutics, Inc. INTS shares fell 9.4% to $8.94 after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.
  • AerSale Corporation ASLE shares fell 8% to $13.60. AerSale priced its secondary offering of 4 million common shares.
  • B. Riley Financial, Inc. RILY fell 7.6% to $19.95.
  • Adobe Inc. ADBE fell 6.2% to $585.55. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.


Now Read This: 'Wait For A Pullback — You're Late To The Party': Jim Cramer Says About This Tech Stock

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!